Heart Defects, Congenital Clinical Trial
Official title:
International Randomized Double Blind Study Evaluating the Efficacy and the Safety of Clopidogrel 0.2 mg/kg Once Daily Versus Placebo in Neonates and Infants With Cyanotic Congenital Heart Disease Palliated With Systemic to Pulmonary Artery Shunt
Contemporary management of cyanotic congenital heart disease includes three stages of
surgery. Incidence of shunt thrombosis and death between the two first stages of palliation
remains important.
The primary objective of the study is to evaluate the efficacy of Clopidogrel 0.2 mg/kg/day
for the reduction of all cause mortality and shunt related morbidity in neonates or infants
with cyanotic congenital heart disease palliated with a systemic-to-pulmonary artery shunt
(e.g. modified Blalock Taussig Shunt [BTS]).
The secondary objective was to assess the safety of Clopidogrel in the study population.
In this event-driven study, participants were to be randomized and treated as soon as
possible after shunt placement. They were then to be treated and followed until the primary
endpoint criteria was reached i.e. (shunt thrombosis, the next surgical procedure for
correction of the congenital heart disease or death) or one year of age or the common
study-end-date, which ever came first.
The common study-en-date was defined as the date when it was projected that 172 participants
would have reached the primary endpoint criteria.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05330338 -
Genetics of Ventriculo-arterial Discordance
|
N/A | |
Withdrawn |
NCT03405636 -
Xeltis Pulmonary Valved Conduit Safety and Performance Study
|
N/A | |
Completed |
NCT02443662 -
Colloid Osmotic Pressure in Patients With Fontan Circulation
|
||
Terminated |
NCT02519335 -
Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation
|
Phase 1 | |
Completed |
NCT01835392 -
Neuroprotective Effects of Remote Ischemic Preconditioning (RIPC) During Infant Cardiac Surgery
|
N/A | |
Completed |
NCT00371891 -
Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)
|
Phase 4 | |
Completed |
NCT03035552 -
CTICU Pacifier Activated Music Player and Mother's Voice
|
N/A | |
Recruiting |
NCT04581668 -
Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease
|
N/A | |
Enrolling by invitation |
NCT04866537 -
Evaluation of the Diagnostic Performance of Specialized Fetal Cardiac Ultrasound in the CPDPN - Arc Alpin Network
|
||
Completed |
NCT03049540 -
Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function
|
Phase 3 | |
Completed |
NCT02377674 -
Safety and Performance of the COR-VG-001 Conduit in Pediatric Patients for Extracardiac Total Cavopulmonary Connection
|
N/A | |
Completed |
NCT01679275 -
Pre-operative Cerebral Oxygenation in Neonates With Congenital Heart Disease
|
||
Terminated |
NCT00543309 -
Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery
|
Phase 2 | |
Completed |
NCT03957512 -
Livet Skal Leves (A Life to Live)
|
||
Recruiting |
NCT06005428 -
Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
|
Phase 2 | |
Recruiting |
NCT02691689 -
Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
|
N/A | |
Completed |
NCT02306057 -
Fluid Balance in Children Undergoing Fontan Surgery
|
N/A | |
Recruiting |
NCT02157597 -
NIRS Guidance Trail in Children's Heart Surgery
|
N/A | |
Completed |
NCT01570933 -
Feasibility Study Over the NAVA Mode in Noninvasive Ventilation After Cardiac Surgery in Infants.
|
Phase 4 | |
Completed |
NCT00443599 -
SPECS: Safe Pediatric Euglycemia in Cardiac Surgery
|
N/A |